×
OVA-1.com / ASPiRAlab.com by. Figure 1. Risk Stratification by OVA1 vs ROMA1*. ROMA. 60. 100. Sensitivity. (%). Pre-menopausal. Post-menopausal. Combined. 89.
People also ask
ROMA and OVA1 (MIA) have the same FDA intended use. Both tests are used to assess the cancer risk of adnexal masses prior to surgery and must be interpreted in ...
The ROMA value is intended to aid in assessing whether a premenopausal or postmenopausal woman who presents with an ovarian adnexal mass is at high or low ...
Jan 1, 2015 · We evaluated the clinical performance of OVA1 and ROMA for the prediction of malignancy in women with an adnexal mass. Methods: One hundred ...
Risk assessment for finding an ovarian malignancy during surgery in women who present with an adnexal mass. The test is not intended as a screening or ...
Missing: ova- | Show results with:ova-
Oct 25, 2012 · Submit CPT code 84999 for OVA 1 and ROMA testing for ovarian cancer. CGS will review the supporting documentation for individual claims to ...
... ROMA and OVA1 tests. The development and evaluation of those tests are described in this review. Thus while effective routine screening for ovarian cancer ...
Apr 22, 2013 · For dates of service prior to January 1, 2013, submit CPT code 84999 for OVA 1 and ROMA testing for ovarian cancer.
ova-roma from store.steampowered.com
The glory of Rome is at your fingertips in this city-building game where you must appease the gods, enact laws, and develop complex supply chains to meet ...